NF-κB as a Therapeutic Target in Multiple Myeloma
Top Cited Papers
Open Access
- 1 May 2002
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 277 (19) , 16639-16647
- https://doi.org/10.1074/jbc.m200360200
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- IKKβ Is Essential for Protecting T Cells from TNFα-Induced ApoptosisImmunity, 2001
- Apaf-1/Cytochrome c-independent and Smac-dependent Induction of Apoptosis in Multiple Myeloma (MM) CellsJournal of Biological Chemistry, 2001
- NF-κB Regulates Transcription of the Mouse Telomerase Catalytic SubunitJournal of Biological Chemistry, 2000
- Adhesion to fibronectin via β1 integrins regulates p27kip1 levels and contributes to cell adhesion mediated drug resistance (CAM-DR)Oncogene, 2000
- RAFTK/PYK2-dependent and -independent apoptosis in multiple myeloma cellsOncogene, 1999
- Thalidomide — A Revival StoryNew England Journal of Medicine, 1999
- Antitumor Activity of Thalidomide in Refractory Multiple MyelomaNew England Journal of Medicine, 1999
- Requirement for NF-κB in osteoclast and B-cell developmentGenes & Development, 1997
- THE NF-κB AND IκB PROTEINS: New Discoveries and InsightsAnnual Review of Immunology, 1996
- Interleukin-6 Inhibits Apoptosis of Malignant Plasma CellsCellular Immunology, 1995